Almost 40 years ago, the discovery of the vasoactive neuropeptide calcitonin gene-related peptide (CGRP) ushered in a new era in migraine treatment.

A new Therapeutics Review explores the current role of CGRP and future perspectives.

Read this & more 👉 https://tinyurl.com/e2vyazf8